[What is to be made of the therapy of borreliosis with cholestyramine and pioglitazone?].
Hassler
Dieter
D
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002792:Cholestyramine Resin / Q000627:therapeutic use*; D002908:Chronic Disease; D006801:Humans; D008193:Lyme Disease / Q000175:diagnosis / Q000188:drug therapy*; D009498:Neurotoxins / Q000378:metabolism; D000077205:Pioglitazone; D013844:Thiazoles / Q000627:therapeutic use*; D045162:Thiazolidinediones; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D009498:Neurotoxins; D013844:Thiazoles; D045162:Thiazolidinediones; D002792:Cholestyramine Resin; D000077205:Pioglitazone